You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
港股異動 | 榮昌生物-B(9995.HK)漲超5% Q1銷售額超去年全年 機構指業績有望超市場預期
格隆匯4月29日丨榮昌生物-B(9995.HK)漲超5%,報32.4港元,總市值176億港元。該公司昨日發佈業績,公司Q1收入1.50億元,超過21年全年的1.31億元;歸母淨虧損同比擴大至2.87億元。國泰君安點評稱,業績符合預期。核心產品放量帶動收入增長,一季度銷售額已超過21年全年。期內銷售費用率54%,管理費用率33%,財務指標健康。季末在手貨幣資金38.9億元,現金儲備充裕。在兩款主打藥物逐步驗證過程中,下一步發展有望超市場預期。維持“增持”評級。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account